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For information regarding this article, E-mail: naim@email.chop.edu Objectives: Treatment algorithms for cardiac arrest are rescuer centric and vary little from patient to patient. The objective of this study was to determine if cardiopulmonary resuscitation-targeted to arterial blood pressure and coronary perfusion pressure rather than optimal guideline care would improve 24-hour survival in a porcine model of ventricular fibrillation cardiac arrest. Data Sources: Preclinical animal laboratory using female 3-monthold swine. Study Selection: A randomized interventional study. Data Extraction: After induction of anesthesia and 7 minutes of untreated ventricular fibrillation, 16 female 3-month-old swine were randomized to 1) blood pressure care: titration of chest compression depth to a systolic blood pressure of 100 mm Hg and vasopressor dosing to maintain coronary perfusion pressure of greater than 20 mm Hg or 2) guideline care: chest compression depth targeted to 51 mm and standard guideline vasopressor dosing. Animals received manual cardiopulmonary resuscitation for 10 minutes before the first defibrillation attempt and standardized postresuscitation care for 24 hours.
Data Synthesis: Twenty-four-hour survival was more likely with blood pressure care versus guideline care (0/8 vs 5/8; p < 0.03), and all survivors had normal neurologic examinations. Mean coronary perfusion pressure prior to defibrillation was significantly higher with blood pressure care (28 ± 3 vs 10 ± 6 mm Hg; p < 0.01). Chest compression depth was lower with blood pressure care (48 ± 0.4 vs 44 ± 0.5 mm Hg; p < 0.05), and the number of vasopressor doses was higher with blood pressure care (median, 3 [range, 1-7] vs 2 [range, 2-2]; p < 0.01). Conclusions: Individualized goal-directed hemodynamic resuscitation targeting systolic blood pressure of 100 mm Hg and coronary perfusion pressure of greater than 20 mm Hg improved 24-hour survival compared with guideline care in this model of ventricular fibrillation cardiac arrest. (Crit Care Med 2016; 44:e1111-e1117) Key Words: cardiac arrest; cardiopulmonary resuscitation; coronary perfusion pressure; ventricular fibrillation; swine I n-hospital cardiac arrest remains a significant problem with approximately 200,000 patients receiving cardiopulmonary resuscitation (CPR) during their hospitalization (1) . Recent studies show that 59% of adults and 93% of children have their in-hospital cardiac arrests in ICUs (2, 3) . Despite improvements in outcomes over the past decade, less than 25% of adults and 50% of children survive to hospital discharge (3, 4) .
Current resuscitation algorithms based on the American Heart Association (AHA) Guidelines recommend chest compressions (CC) targeted to a depth greater than 51 mm (5, 6) . The AHA also recommends monitoring resuscitation efforts using arterial blood pressure (BP), when feasible. The most important determinant of return of spontaneous circulation (ROSC) during CPR is myocardial blood flow (7, 8) , which is driven by coronary perfusion pressure (CPP) (the difference between the aortic and right atrial diastolic pressures) (9, 10) . CPP can be measured in patients who have arterial and central venous lines. We have proposed an alternative strategy to the "one size fits all" CC depth-guided resuscitation: an individualized approach based on a patient's hemodynamic response to resuscitative efforts (11) (12) (13) .
We have previously shown that individualized BP-and CPP-targeted care (BP care) to achieve a systolic BP (SBP) of greater than 100 mm Hg and a CPP greater than 20 mm Hg during CPR for ventricular fibrillation (VF) improved shortterm (45 min) survival compared with standard guideline care targeted to achieve a CC depth of greater than 51 mm (12) . The objective of this study was to assess whether BP care would improve 24-hour survival and 24-hour survival with favorable neurologic outcome compared with guideline care in a porcine model of VF cardiac arrest.
MATERIALS AND METHODS

Animal Preparation
The University of Pennsylvania Institutional Animal Care and Use Committee (IACUC) approved the experimental protocol.
Sixteen 3-month-old female domestic swine were anesthetized and mechanically ventilated on a mixture of room air and titrated isoflurane (≈ 1.0-2.5%) with a tidal volume of 10-12 mL/kg, positive-end expiratory pressure of 6 cm H 2 O, and titration of ventilation rate to maintain end-tidal carbon dioxide (ETco 2 ) at 38-42 mm Hg (NICO, Novametrix Medical Systems, Wallingford, CT). Rectal temperature was monitored continuously, and the animals were placed on a warming blanket if needed to maintain normothermia.
Continuous aortic and right atrial pressures were measured using solid-state, micromanometer-tipped catheters (MPC-500, Millar Instruments, Houston, TX) advanced through the right femoral artery and external jugular vein into thoracic locations. Cardiac output and pulmonary artery pressure measurements were obtained with a Swan-Ganz thermodilution catheter (Edwards Lifesciences, Irvine, CA) that was advanced into the pulmonary artery. VF was induced through a bipolar pacing catheter (Edwards Lifesciences). Unfractionated heparin (200 U/kg) was provided to prevent catheter clotting. All animals received 20 mL/kg 0.9% normal saline IV to replace overnight fasting fluid deficits prior to any baseline measurements.
Measurements
Baseline thermodilution cardiac outputs (ICU monitor: model HP66, Hewlett Packard, Palo Alto, CA) were obtained prior to induction of VF. Arterial blood gas specimens were obtained from the thoracic aorta at baseline, at the end of untreated VF, and after 6 minutes of CPR. Mean CPP during CPR was calculated by the difference between the aortic pressure and the right atrial pressure during the relaxation phase of CPR ("diastolic period").
The Philips Heart Start MRx defibrillator (Philips Medical Systems, Andover, MA) with Q-CPR option and a metronome were used to guide and record manual CPR quality. This defibrillator records CPR quality and provides audiovisual feedback to the CC provider for rate (CC/min), depth (mm), and incomplete chest wall recoil (residual leaning force) using force transducer/accelerometer technology (14) (15) (16) (17) .
Experimental Protocol
VF was induced by electrical pacing. After confirmation of VF, the animals remained intubated but were disconnected from mechanical ventilation. Following 7 minutes of untreated VF, animals received one of the two CPR and advanced life support strategies for a 10-minute duration before attempts at defibrillation. A 10-minute interval of CPR was chosen before defibrillation as a practical approach because this duration of CPR is necessary to adequately compare CPR techniques. In addition, most in-hospital CPR is at least 10 minutes in duration for both survivors and nonsurvivors (18, 19) . If the animals are defibrillated more promptly, they have immediate ROSC and do not need CPR. The 7-minute untreated VF period was included, so that the insult would be severe enough to allow discrimination of outcomes between the two protocols ( Fig. 1) .
In both treatment arms, metronome-guided CCs were provided with a target rate of 100 CC/min. At the initiation of CPR, mechanical ventilation was resumed at a rate of 6 breaths/minute with 100% oxygen. CPR was interrupted every 2 minutes for up to 4 seconds to mimic pulse checks and rhythm analyses. Animals received one of the two resuscitation strategies: 1) BP care: titration of CC depth to an SBP of 100 mm Hg and vasopressor dosing to maintain CPP greater than 20 mm Hg or 2) guideline care: CC depth targeted to 51 mm and standard guideline vasopressor dosing. Guideline vasopressor dosing included IV epinephrine (0.02 mg/kg) every 4 minutes starting at minute 9 of the protocol (2 min after CPR was started). Animals in the BP care group received IV vasopressor only if the CPP was less than 20 mm Hg, also starting at minute 9 of the protocol. The order of drug administration for BP care was epinephrine (0.02 mg/kg) followed by epinephrine (0.02 mg/kg) and then vasopressin (0.4 U/ kg). The dosing interval was 1 minute between epinephrine doses, and 2 minutes after a vasopressin dose. After 10 minutes of CPR (minute 17 of the protocol), an initial 200-J biphasic waveform defibrillation attempt was provided. CPR according to treatment strategy continued until there was sustained ROSC or until minute 27 of the protocol (after an additional 10 min of resuscitation post initial defibrillation attempt). If ROSC was attained, the animals then received postcardiac arrest care according to protocol. Any animals not achieving ROSC received postmortem examination for the detection of visceral injuries that may have contributed to unsuccessful resuscitation.
Post-Cardiac Arrest Care
Animals that achieved ROSC received protocolized intensive care treatment that included 1) titration of oxygen concentration to maintain oxygen saturation 92-94%; 2) titration of ventilation (tidal volume [6-10 mL/kg] and ventilation rate) to maintain ETco 2 between 38 and 42 mm Hg; and 3) IV infusions of dopamine (≤ 20 μg/kg/min), as needed, to maintain mean arterial pressure greater than 55 mm Hg. Anesthesia was maintained with inhaled isoflurane (≈ 1.0-2.5%), titrated to comfort, during this time period. All animals received buprenorphine (0.02 mg/kg intramuscular every 6 hr) for pain control. By 4 hours post ROSC, vasopressor support was weaned and discontinued, and the animals were extubated. At 24 hours, all animals were neurologically assessed using the previously validated swine cerebral performance category (SCPC) (20, 21) , performed by two experienced research technicians who agreed on the final score.
Data Analysis/Outcomes
The primary outcome of this study was 24-hour survival. Secondary outcomes were 1) any ROSC, 2) 45-minute survival, 3) 24-hour survival with favorable neurologic outcome, 4) hemodynamic measures (specifically mean CPP), and 5) CPR quality variables. A favorable neurologic outcome was defined as an SCPC as 1-2 at 24 hours. The Skewness-Kurtosis test was used to assess normality of continuous variables. Mean ± sem were used to describe normally distributed continuous variables, which were compared by Student t test. Continuous variables that were not normally distributed were described as median and interquartile range (25-75%) and evaluated by Wilcoxon signed rank test. Fisher exact test was used to evaluate the comparisons of dichotomous variables, such as survival outcomes. Differences in CPR quality variables and differences in CPPs over time and between treatment groups and between survivors/nonsurvivors were assessed using generalized estimating equations (GEE) with an identity link. A robust variance estimator with an exchangeable correlation structure was used to account for longitudinal correlation, which arose from collecting observations on the same study animals over time. For our primary outcome, 10 animals were randomly assigned to each treatment protocol to have at least 80% power to detect a difference similar to survival in our short-term survival studies (37.5% in the guideline care group and 100% in the BP care group). Because there were no survivors in the first eight animals of the guideline care control group, our IACUC asked us to analyze the data in an attempt to reduce the number of animals needed in accordance with the National Institutes of Health Animal Use Policy (22) . Stata-IC statistical package (version 12.0, StataCorp, College Station, TX) was used to perform the statistical analysis.
RESULTS
Primary outcome of 24-hour survival and secondary outcomes of any ROSC, 45-minute survival, and 24-hour survival with favorable neurologic outcome were all significantly higher in the BP care group compared with guideline care ( Table 1 ). In a model using GEEs, CPP (Fig. 2) was significantly higher in the BP care group compared with guideline care (point estimate, +11.7 mm Hg; 95% CI, 4.5-18.9 mm Hg; p < 0.01). Survivors at 24 hours tended to have higher CPPs than nonsurvivors who were not statistically significant (point estimate, +7.8 mm Hg; 95% CI, -1.53 to 17.1 mm Hg; p = 0.10). All survivors had an SCPC of 1 (normal, no difficulty standing, walking, eating, drinking, alert, and fully responsive) at 24 hours. None of the survivors had fever in the post-cardiac arrest phase. Postmortem examination in nonsurvivors showed no visceral injuries that may have contributed to unsuccessful resuscitation.
Resuscitation Variables
Mean CC depth was significantly different among groups: 44 ± 0.5 mm with BP care versus 48 ± 0.4 mm with guideline care (p = 0.049). Other CPR quality variables were not different between the two groups (rate = 100 ± 0.2 CC/min; CC fraction = 97% ± 0.3%; and no CCs delivered had leaning exceeding 2.5 kg). The total number of vasopressor doses administered prior to first defibrillation attempt after 10 minutes of resuscitation was significantly higher in the BP care group compared with guideline care (median, 3 [range, 1-7] vs 2 [range, 2-2]; p = 0.006). The median number of defibrillation attempts to terminate VF and lead to sustained ROSC in survivors was 1 (range, 1-3). Of the 7 animals achieving 45-minute survival, 5 (71%) required vasopressor support to maintain goal BPs during the 4 hour post cardiac arrest period (dopamine infusion: mean peak dose, 12 ± 2 μg/kg/min). One surviving animal in the BP care group required cardioversion for unstable narrow complex supraventricular tachycardia during the 4 hour post cardiac arrest period after ROSC.
Hemodynamics and Arterial Blood Gases
At prearrest baseline, hemodynamic variables were not different. The mean diastolic CPP was higher in the BP care group at the end of the untreated VF period compared with guideline care: 6 ± 2 versus 1 ± 1 mm Hg (p = 0.03). At the end of the resuscitation period, the BP care group had higher diastolic BP compared with guideline care (42 ± 3 vs 27 ± 6 mm Hg; p = 0.04) and mean CPP (28 ± 3 vs 10 ± 6 mm Hg; p < 0.01). There were no differences in mean ETco 2 between the groups throughout the CPR period or ETco 2 at the end of the resuscitation period. There were no differences in arterial blood gases obtained at the end of the untreated VF period or after 6 minutes of CPR; however, the BP care group had a higher pH at baseline (Tables 2 and 3 ).
DISCUSSION
In this study, we have demonstrated that individualized BPand CPP-targeted CPR improves 24-hour survival and 24-hour survival with favorable neurologic outcomes compared with depth-targeted AHA guideline care in a porcine model of VF cardiac arrest. The BP care group attained higher CPP despite slightly lower CC depth. As expected, the BP group received more vasopressor doses overall, yet the wide range of doses required highlights the variability of resuscitation needs, and some survivors in the BP group only received one vasopressor dose during the entire 10 minutes of CPR.
This animal model was intended to address whether individualized BP-and CPP-targeted CPR could improve outcomes. We provided CPR for 10 minutes because most in-hospital CPR is provided for at least 10 minutes to both survivors and nonsurvivors (18, 19) . Rather than defibrillate these animals promptly, we left them in VF, so that we could provide the same duration of CPR to both the experimental BP care group and the guideline care group. If we had defibrillated the animals earlier, the animals would have had variable times to ROSC, so we would have not been able to compare the CC and vasopressor strategies. We had previously shown that BP care improved rates of ROSC and 45-minute survival, but it was possible that this approach would not result in longer duration survival or that the survivors would have been neurologically devastated. These exciting findings provide a proof-in-concept, but further data are necessary for applications in patients. Most in-hospital cardiac arrests occur in ICUs (2, 3) , and more than 10% of these ICU patients have invasive arterial BP monitoring (18) . For these patients, a BP-directed approach is possible. Yet, we do not know the optimal CPP for human CPR. Nevertheless, these data support the biologically plausible concept that individualized hemodynamic titrated CPR can improve outcomes compared with rescuer-centric resuscitation protocols.
The AHA has placed a great emphasis on high-quality CPR, which includes CCs at a rate of 100 per minute, ventilation of 6 breaths/minute, no residual leaning, and compressing to an optimal depth of 51 mm (6, 23, 24) . Previous investigations have shown that deeper compressions are associated with improved outcomes (25) (26) (27) ; however, in this present study, CC depth was slightly lower in the BP-targeted group compared with the guideline care group (i.e., depth alone does not guarantee adequate arterial pressures). The wide range of doses of vasopressors administered to the BP care group, including some animals that received only one vasopressor dose, suggests that an individualized approach to resuscitation may have additional benefits by giving vasopressors only when they are needed. Although speculative, the success of the individualized approach may be that it allows rescuers to avert potential harm of both: 1) overly deep compressions and/or 2) vasopressor use when they are not required. By titrating CPR effect to BP, compressions that were too deep for a given "patient" were avoided, and unnecessary vasopressors that could adversely affect myocardial bioenergetics during CPR and afterload after ROSC were avoided when they were not needed to maintain CPP during CPR.
ETco 2 monitoring has been recommended during resuscitation by the AHA and correlates with cardiac output and resuscitation outcomes (6, 23, 24, 28) . In the present study, there were no differences in mean ETco 2 during CPR in the two groups. These data suggest that monitoring invasive hemodynamic measurement of CPP during CPR is superior to ETco 2 monitoring during CPR.
An important finding in our study was the excellent neurologic outcome in animals that survived after receiving BP-directed CPR. Previous work by our group with cerebral monitoring of intracranial pressure and brain tissue oxygenation has demonstrated higher cerebral perfusion pressures and brain oxygen tension during CPR in animals that received BP care for a VF cardiac arrest compared with guideline care (29) . This finding is significant as hypoxic-ischemic brain injury causes significant morbidity in survivors of cardiac arrest. In the present investigation, neurologic testing was performed using the SCPC, which provides a gross evaluation of overall neurologic function.
This study has several limitations. This is an animal study in anesthetized healthy young swine without coronary artery disease. The findings are only potentially applicable to patients who have invasive monitoring in place at the time of arrest. However, large epidemiological studies have established that the majority of in-hospital cardiac arrests occur in ICUs (2) (3) (4) , and some of these patients have an arterial line in place at the time of arrest (18) . At the end of the untreated VF period, the BP-targeted group had a statistically higher diastolic CPP (6 vs 1 mm Hg) and higher baseline pH compared with the BP care group (7.56 vs 7.52). The animals were randomized before each study to one or the other group, and it is not unusual to have one of the many sets of measurements be statistically different when so many comparisons are analyzed. Importantly, the CPP was similarly quite low in both groups, and the pH was not clinically different in the two groups. In the BP care group, the overall median number of vasopressors prior to defibrillation was higher compared with the guideline care group (median, 3 [range, 1-7] vs 2 [range, ; p = 0.006), as would be expected because the experimental protocol in the BP care group could result in 0-7 doses of vasopressor per animal, whereas the guideline care group all received 2 doses prior to the first defibrillation attempt. In part, the higher CPPs in the BP group resulted from the titrated higher vasopressor dosage. However, it is important to note that there was a wide range of vasopressor doses administered to the BP-titrated group, and some of the 24-hour survivors in the BP care group received only one vasopressor dose. Therefore, the number of doses alone does not explain the differences in outcomes between the two groups. We were not able to compare neurologic outcome between survivors in the BP care group and guideline care group as there were no survivors in the guideline care group. Although neurologic outcome was favorable at 24 hours in survivors by the SCPC, complex neurobehavioral testing was not performed. Nevertheless, all survivors were walking normally and drinking normally. Anesthesia was provided with isoflurane, which may have protective properties (30, 31) ; however, isoflurane was provided to all animals in both groups, yet, survival only occurred in the BP care group. Finally, our study was not blinded, so objective measures for rate, depth, leaning and ventilation, and strict adherence to a prospective post-cardiac arrest protocol were implemented to minimize the risk of bias.
CONCLUSIONS
In this animal model, individualized goal-directed resuscitation targeting SBP greater than 100 mm Hg and CPP greater than 20 mm Hg improved 24-hour survival compared with guideline "one size fits all" rescuer-centric care. This approach is a promising strategy for use in invasively monitored ICU patients. Guideline care refers to depth-guided cardiopulmonary resuscitation at 51 mm and standard American Heart Association vasopressor dosing intervals. Blood pressure (BP) care refers to compression depth titrated to systolic BP of 100 mm Hg and vasopressor dosing titrated to attain coronary perfusion pressure of greater that 20 mm Hg.
